Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1993
03/18/1993WO1993004681A1 Use of antagonists or partial agonists on the 5-ht1a receptor for the treatment and prevention of cognitive disorders
03/18/1993WO1993004680A1 Macrocyclic immunomodulators
03/18/1993WO1993004678A1 Antimicrobial preservation of platelets and blood factors
03/18/1993WO1993004677A1 Anti-inflammatory analgesic plaster
03/18/1993WO1993004676A1 High content ibuprofen agglomerates and process to prepare them
03/18/1993WO1993004675A1 Composition comprising a tramadol material and acetaminophen and its use
03/18/1993WO1993004669A1 Use of n-acetyl-l-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
03/18/1993WO1993000099A3 Use of pyrimidine and purine nucleosides for the prophylaxis and/or treatment of infections caused by adenoviruses
03/18/1993WO1992020711A3 Lhrh antagonists and intermediate products
03/18/1993DE4130933A1 Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln New (beta) -carbolinderivate whose production and use in medicinal products
03/18/1993DE4130918A1 Alpha-sympatholytic and beta-sympathomimetic contg. solns. - for injection after dental anaesthesia to relieve vasoconstriction and reduce anaesthetic effect
03/18/1993DE4125871A1 Dermatological preparations contg. tocopherol and isoprenoid lipid - synergise antibiotics, corticoid(s) and chemotherapeutics in treatment of eczema, allergy and esp. acne
03/18/1993CA2305767A1 Steroid sulphatase inhibitors
03/18/1993CA2305758A1 Steroid sulphatase inhibitors
03/18/1993CA2305749A1 Steroid sulphatase inhibitors
03/18/1993CA2118798A1 Azabicyclic compounds as 5-ht4 receptor antagonists
03/18/1993CA2118697A1 Indole derivatives as 5-alpha-reductase inhibitor
03/18/1993CA2117196A1 Process for the preparation of the dextrogyral isomer of an isoindolinone derivative
03/18/1993CA2117075A1 Quinazoline derivatives and their preparation
03/18/1993CA2117070A1 Methods for the selection, separation and fusion of cells
03/18/1993CA2117062A1 New tricyclic thiazole and oxazole derivatives and pharmaceutical agents containing them
03/18/1993CA2116680A1 6((2-hydroxyethyl)amino alkyl)-5,11-dioxo-5,6- dihydro-11-h-indeno(1,2-c)isoquinoline and their use as antineoplastic agents
03/18/1993CA2116549A1 Compositions and methods for treating wounds
03/18/1993CA2116437A1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutica l forms containing it
03/18/1993CA2116431A1 Composition and method for reducing cholesterol concentration
03/18/1993CA2116229A1 Bicyclic sulfones, processes for their production and pharmaceutical agents containing them
03/18/1993CA2116107A1 Targeted delivery of poly-or oligonucleotides to cells
03/18/1993CA2115844A1 Antidepressant polycyclic imides
03/18/1993CA2115161A1 New compounds
03/18/1993CA2113818A1 Spirocyclic benzopyran imidazolines
03/18/1993CA2095847A1 Novel 4-arylpiperazines and 4-arylpiperidines
03/18/1993CA2093009A1 Use of antagonists or partial agonists on the 5-ht 1a receptor for the treatment and prevention of cognitive disorders
03/17/1993EP0532466A2 Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use
03/17/1993EP0532456A1 1-Acylpiperidine derivatives and their use as substance P antagonists
03/17/1993EP0532446A1 Use of xanthines in the treatment or prevention of hypeoglycemia
03/17/1993EP0532423A1 Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
03/17/1993EP0532410A1 N-substituted heterocyclic derivatives as angiotensin II inhibitors
03/17/1993EP0532398A1 N-(4,7-dimethoxyindan-2-yle)-1-(phenylcarbonyl)-N-propyle-piperidine-4-methane amines, their preparation and their therapeutical application
03/17/1993EP0532369A2 Furth therapeutical uses of L-methionine and compositions
03/17/1993EP0532348A2 A tramadol N-oxide material, enantiomers and compositions thereof, and their use
03/17/1993EP0532239A1 Benzenesulphonamide derivatives as 5-lipoxygenase inhibitors
03/17/1993EP0532190A2 Benzo f quinolinones as 5-alpha-reductase inhibitors
03/17/1993EP0532178A1 Methanoanthracenes as dopamine antagonists
03/17/1993EP0532177A1 Methanoanthracenes as dopamine antagonists
03/17/1993EP0532156A1 Physiologically active diterpenoid
03/17/1993EP0532097A1 Piperazinyl(sulfon)amide derivatives of camphor as oxytocin antagonists
03/17/1993EP0532091A1 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)-phenyl)-5-methyl-3H-1,2,4-triazol-3-one derivatives as 5-lipoxygenase inhibitors
03/17/1993EP0532089A1 N-heteroaryl, N-alkylheteroaryl, N-alkenylheteroaryl & N-alkynylheteroarylmacrolides
03/17/1993EP0532088A1 O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroaryl macrolides
03/17/1993EP0532054A1 Process for preparing alpha,alpha-disubstituted aromatics and heteroaromatics as cognition enhancers
03/17/1993EP0532027A1 Cyclic nitrones, their preparation and pharmaceutical compositions containing them
03/17/1993EP0532026A2 Oligosaccharide aromatic glycoside sulfate
03/17/1993EP0531981A1 Process for the preparation of a cephalosporin antibiotic
03/17/1993EP0531958A1 6-Aminoquinolones, their synthesis and their use as antibacterial agents
03/17/1993EP0531901A2 Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity
03/17/1993EP0531883A1 Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them
03/17/1993EP0531876A2 Imidazoindolizine derivatives and process for preparation thereof
03/17/1993EP0531875A2 Diastereomers of the 3-cephem-4-carboxylic acid-1-(-isopropoxycarbonyloxy)ethylester and process for their preparation
03/17/1993EP0531845A1 Pharmaceutical composition comprising a special crystall modification of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbonylic acid-(-2-methoxyethyl)-isopropyl ester
03/17/1993EP0531823A1 Bicyclic carboxylic acid derivatives as anti-inflammatory agents
03/17/1993EP0531642A1 Antibiotic LL-E19020 Zeta and LL-E 19029 Eta
03/17/1993EP0531640A1 Antibiotic LL-E19020 Gamma
03/17/1993EP0531638A1 Antibiotic LL-E19020 alpha 1
03/17/1993EP0531637A1 Recovery process for antibiotics LL-E19020 alpha and beta
03/17/1993EP0531598A1 1,4-Dihydropyridines with paf-antagonistic activity
03/17/1993EP0531597A1 Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
03/17/1993EP0531548A1 Carbostyril derivatives as anti-thrombotic agents
03/17/1993EP0531529A1 Process for preparing aqueous suspension
03/17/1993EP0531452A1 Synthesis of glycerol di- and triphosphate derivatives
03/17/1993EP0531447A1 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna
03/17/1993EP0531443A1 Methods for treating inflammation and compounds and compositions suitable for use therein
03/17/1993EP0531434A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity
03/17/1993EP0531419A1 Bistriazenes as chemotherapeutic agents
03/17/1993EP0531413A1 An antiviral composition containing prostratin
03/17/1993EP0531382A1 N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders
03/17/1993EP0531369A1 1,4-dihydropyridines for application in combatting resistance to drugs
03/17/1993EP0531365A1 Diagnosis and treatment of viral hepatitis
03/17/1993EP0531349A1 1-7 substituted xanthine derivatives having antiasthmatic activity, their salts physiologically acceptable, pharmaceutical composition containing them and process for their preparation
03/17/1993EP0531282A1 Production and use of porphyrin derivatives and of compositions containing such derivatives
03/17/1993EP0516685A4 Artificial tears
03/17/1993EP0425505B1 Transdermal antisecretory agents for gastrointestinal disease
03/17/1993EP0383759A4 N?6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
03/17/1993EP0360821B1 Pharmaceutical compositions for treating adrenoleukodystrophy
03/17/1993EP0345308B1 Ornithine derivatives and their use as inhibitors of methotrexate resistant cells
03/17/1993EP0276317B1 Gamma-l-glutamyl-l-cysteine ethyl ester and drug containing it as effective ingredient
03/17/1993EP0266426B1 Pseudouridine derivative
03/17/1993EP0250542B1 Transdermal delivery system
03/17/1993EP0233271B1 Process for preparing cephalosporin intermediates
03/17/1993CN1069981A Mono and bis alkylamino-anthracyclines
03/17/1993CN1069976A Cyclohexan and tetrahydropyran derivatives
03/17/1993CN1069974A Triazolyl-substituted tertiary amino compounds and their salts
03/17/1993CN1069973A Corbostyril derivatives and pharmaceutical compostions contaiming same
03/17/1993CN1069971A Novel sulfonamide fibrinogen receptor antagonists
03/17/1993CN1069969A Synthetic aryl polyamines as exicitatory/amino acid neurotransmitter antagonists
03/17/1993CN1069965A Method and compositions for isolating taxanes
03/17/1993CN1069883A Control and prevention of poultry mycosis
03/17/1993CN1069882A Compounds and methods for inhibition of HIV and related viruses
03/17/1993CN1020107C Process for antivirotic compound
03/17/1993CN1020106C Process for pyrimidine derivatives
03/17/1993CN1020104C Process for preparing cephene device
1 ... 7207 7208 7209 7210 7211 7212 7213 7214 7215 7216 7217 7218 7219 7220 7221 7222 7223 7224 7225 7226 7227 ... 7860